Wanbury to settle debt by selling few brands

23 Sep 2019 Evaluate

Wanbury has received approval for debt settlement and fund raising plan by sale of few brands. The Board of Directors of the Company at its meeting held on September 20, 2019 has approved the same.

Wanbury is the fastest growing pharma company and has a strong presence in the domestic branded formulations.

Wanbury Share Price

145.00 3.50 (2.47%)
28-Mar-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.50
Dr. Reddys Lab 6171.85
Cipla 1494.65
Zydus Lifesciences 1013.75
Lupin 1617.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.